Reinhard Kirnbauer

Vienna, Austria

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 34 publications

Filamentous virions act as non-infectious interfering particles to modulate papillomavirus infection.

Filamentous virions act as non-infectious interfering particles to modulate papillomavirus infection.

Journal: Journal of virology
Published: January 13, 2026

The Controversial Link Between Human Papillomavirus Infection and Esophageal Health: An Exploratory Translational Study.

The Controversial Link Between Human Papillomavirus Infection and Esophageal Health: An Exploratory Translational Study.

Journal: Pathogens (Basel, Switzerland)
Published: December 18, 2025

German-Austrian guideline on screening for anal dysplasia and anal carcinoma in people living with HIV.

German-Austrian guideline on screening for anal dysplasia and anal carcinoma in people living with HIV.

Journal: Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
Published: February 04, 2025

BRAF Inhibition and UVB Light Synergistically Promote Mus musculus Papillomavirus 1-Induced Skin Tumorigenesis.

BRAF Inhibition and UVB Light Synergistically Promote Mus musculus Papillomavirus 1-Induced Skin Tumorigenesis.

Journal: Cancers
Published: August 07, 2024

Immune profile diversity is achieved with synthetic TLR4 agonists combined with the RG1-VLP vaccine in mice.

Immune profile diversity is achieved with synthetic TLR4 agonists combined with the RG1-VLP vaccine in mice.

Journal: Vaccine
Published: March 25, 2024

Cross-neutralizing protection of vaginal and oral mucosa from HPV challenge by vaccination in a mouse model.

Cross-neutralizing protection of vaginal and oral mucosa from HPV challenge by vaccination in a mouse model.

Journal: Vaccine
Published: March 31, 2023

Papillomavirus-like Particles in Equine Medicine.

Papillomavirus-like Particles in Equine Medicine.

Journal: Viruses
Published: December 21, 2022

Next generation L2-based HPV vaccines cross-protect against cutaneous papillomavirus infection and tumor development.

Next generation L2-based HPV vaccines cross-protect against cutaneous papillomavirus infection and tumor development.

Journal: Frontiers in immunology
Published: August 03, 2022

Polymerase-δ-deficiency as a novel cause of inborn cancer predisposition associated with human papillomavirus infection.

Polymerase-δ-deficiency as a novel cause of inborn cancer predisposition associated with human papillomavirus infection.

Journal: The British journal of dermatology
Published: July 29, 2022

Vaccination with human alphapapillomavirus-derived L2 multimer protects against human betapapillomavirus challenge, including in epidermodysplasia verruciformis model mice.

Vaccination with human alphapapillomavirus-derived L2 multimer protects against human betapapillomavirus challenge, including in epidermodysplasia verruciformis model mice.

Journal: Virology
Published: June 28, 2022

RG2-VLP: a Vaccine Designed to Broadly Protect against Anogenital and Skin Human Papillomaviruses Causing Human Cancer.

RG2-VLP: a Vaccine Designed to Broadly Protect against Anogenital and Skin Human Papillomaviruses Causing Human Cancer.

Journal: Journal of virology
Published: June 15, 2022

Human Papillomavirus 42 Drives Digital Papillary Adenocarcinoma and Elicits a Germ Cell-like Program Conserved in HPV-Positive Cancers.

Human Papillomavirus 42 Drives Digital Papillary Adenocarcinoma and Elicits a Germ Cell-like Program Conserved in HPV-Positive Cancers.

Journal: Cancer discovery
Published: April 29, 2022
Showing 1-12 of 34

Last Updated: 09/26/2026